|
13 Brands |
|
50+ Countries |
|
7 Manufacturing Facilities |
|
1,400 Employees Worldwide |
Atrium Innovations is recognized around the world as an innovative leader in the development, manufacturing, and commercialization of science-based nutritional health products.
Atrium Innovations is headquartered in Montreal, Canada and we have offices and manufacturing plants around the globe. We are a vertically integrated company with seven manufacturing facilities in the U.S., Canada, Europe and Argentina.
Our Purpose
Empowering healthier lives.
Our Mission
Be a global leader in vitamins, minerals and supplements with the largest and fastest growing brands in the markets and channels in which we choose to distribute, with a proven reputation for premium-quality, science-based, professionally recognized products.
Our Commitment
Atrium Innovations is dedicated to promoting the health and well-being of those in need by giving back to local and global charities through our “Growing Together” program.
Our History at a glance
2014
June Peter Luther appointed as President and CEO
February Acquisition of Atrium Innovations by a group backed by the Permira funds
2013
October Atrium Innovations acquires a controlling interest in Mucos Pharma CZ s.r.o., the exclusive distributor of Wobenzym® products in Central and Eastern Europe.
2011
August Acquisition of Enzimas S.A.
April Acquisition of Robert & Fils (Québec) Inc.
2010
December Acquisition of Seroyal
March Acquisition of Trophic Canada
2009
September Acquisition of Garden of Life
January Acquisition of the Wobenzym© family of products manufacturing facility (EAB Enzym‐Arzneimittel‐Berlin GmbH)
2008
December Acquisition of Nutri-Health and its family of brands
September Acquisition of the AOV brand (Orthos Europe BV)
May Atrium Innovations divests its Active Ingredients & Specialty Chemicals Division
February Acquisition of Orthica and its family brands (Multicare B.V.)
2007
July Acquisition of Wobenzym© and its family of brands (Mucos Emulsions GMBH)
May Atrium Biotechnologies Inc. changes its name to Atrium Innovations Inc.
January Acquisition of a liquid-filled capsule manufacturing facility (AquaCap) and its Caplique technology
2006
October Atrium Biotechnologies is spun-off completely from
AEterna Zentaris
September Acquisition of Douglas Laboratories Canada
2005
December Acquisition of Douglas Laboratories
March Atrium becomes a publicly-traded company with an Initial Public Offering
2004
March Acquisition of Pure Encapsulations, Inc.
2000
Two private placements with SGF Soquia Inc. and Fonds de solidarité des travailleurs du Québec (FTQ)
1999
December Atrium Biotechnologies Inc. is established as a separate subsidiary of Æterna Laboratories Inc. (now known as AEterna Zentaris Inc.). Both companies where founded by brothers, Eric and Luc Dupont.